Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Revenue

Amplia Therapeutics had revenue of 1.41M AUD in the half year ending September 30, 2024, a decrease of -20.49%. This brings the company's revenue in the last twelve months to 3.41M, up 82.57% year-over-year. In the fiscal year ending March 31, 2024, Amplia Therapeutics had annual revenue of 4.45M with 274.34% growth.

• Revenue (ttm): 3.41M
• Revenue Growth: +82.57%
• P/S Ratio: 6.14
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 20.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%
Mar 31, 2021	1.53M	1.50M	4,380.44%
Mar 31, 2020	34.23K	-16.25K	-32.19%